By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cincinnati-based diagnostics firm Meridian Bioscience today reported fourth-quarter revenue growth of 16 percent, with sales increases reported for both its diagnostics and life sciences businesses.

Meridian reported total revenues of $41.3 million for the three-month period ended Sept. 30, compared to $35.5 million for the third quarter of 2010. It fell short of analysts' consensus estimate of $42.1 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.